ArticleMedicina intensiva2020
[Guillain-Barré Syndrome Associated with SARS-CoV-2 infection].
Article in Medicina intensiva, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 4 syntheses or guidelines pooled it, 21 citations in OpenAlex.
- Treatment Options for COVID-19-Related Guillain-Barré Syndrome: A Systematic Review of Literature.The neurologist · 2021Pooled it
- Guillain Barré syndrome associated with COVID-19- lessons learned about its pathogenesis during the first year of the pandemic, a systematic review.Autoimmunity reviews · 2021Pooled it
- Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.Journal of neurology · 2021Pooled it
- Pooled it
- Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.International immunopharmacology · 2022Review
- Reply to "Ample evidence suggests SARS-CoV-2 triggers polyradiculitis".Medicina intensiva · 2022Article
- Reply to "Ample evidence suggests SARS-CoV-2 triggers polyradiculitis".Medicina intensiva · 2022Article
- COVID-19 Associated Guillain-Barré Syndrome: A Report of Nine New Cases and a Review of the Literature.Medicina (Kaunas, Lithuania) · 2022Review
- SARS-CoV-2, a new causative agent of Guillain-Barré syndrome?Medicina intensiva · 2022Article
- Demographic, Clinical, and Investigational Characteristics of COVID-19- related Guillain-Barré Syndrome with Differences from Typical and Another Virus-related Guillain-Barré Syndrome.Infectious disorders drug targets · 2022Article
- Peripheral Nervous System Manifestations Associated with COVID-19.Current neurology and neuroscience reports · 2021Review
- Guillain-Barre Syndrome Associated With COVID-19 Infection: A Case Report With Review of Literature.Cureus · 2021Article
- SARS-CoV-2, A new causative agent of Guillain-Barré syndrome?Medicina intensiva · 2020Article
- COVID-19 and Guillain-Barré Syndrome: A Case Report and Review of Literature.Frontiers in neurology · 2020Article
- COVID-19 infection presented as Guillain-Barre Syndrome: Report of two new cases and review of 116 reported cases and case series.Travel medicine and infectious diseaseReview
- [Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review].Neurologia (Barcelona, Spain)Review
Corrections and comments
- Commented on by
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.